Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer
Open Access
- 1 February 1994
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 69 (2) , 392-393
- https://doi.org/10.1038/bjc.1994.72
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.Journal of Clinical Oncology, 1993
- Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.1990
- Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.Journal of Clinical Oncology, 1990
- Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.Journal of Clinical Oncology, 1988
- Head and neck cancer: chemotherapy concepts.1988
- Interferon Inhibits the Establishment of Competence in G 0 /S-phase TransitionScience, 1986
- Reporting results of cancer treatmentCancer, 1981